Targeting EML4-ALK driven non-small cell lung cancer (NSCLC)

被引：16

作者：

Moran, Teresa ^{[1
]}

Quiroga, Vanesa ^{[1
]}

Llanos Gil, Maria de Los ^{[1
]}

Vila, Laia ^{[1
]}

Pardo, Nuria ^{[1
]}

Carcereny, Enric ^{[1
]}

Capdevila, Laia ^{[1
]}

Munoz-Marmol, Ana M. ^{[2
]}

Rosell, Rafael ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Inst Catala Oncol Badalona, Med Oncol Dept, Carretera Canyet S-N, E-08193 Barcelona, Spain

[2] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Pathol Dept, E-08193 Barcelona, Spain

来源：

TRANSLATIONAL LUNG CANCER RESEARCH | 2013年 / 2卷 / 02期

关键词：

D O I：

10.3978/j.issn.2218-6751.2013.03.04

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：128 / 141

页数：14

共 69 条

[1] Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor - Mutant lung adenocarcinomas with acquired resistance to kinase inhibitors [J].

Balak, Marissa N. ;

Gong, Yixuan ;

Riely, Gregory J. ;

Somwar, Romel ;

Li, Allan R. ;

Zakowski, Maureen F. ;

Chiang, Anne ;

Yang, Guangli ;

Ouerfelli, Ouathek ;

Kris, Mark G. ;

Ladanyi, Marc ;

Miller, Vincent A. ;

Pao, William .

CLINICAL CANCER RESEARCH, 2006, 12 (21) :6494-6501

[2]

Blackhall FH, 2012, ANN ONCOL, V23

[3]

Blackhall FH, 2011, 14 WORLD C LUNG CANC

[4] Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas [J].

Boland, Jennifer M. ;

Erdogan, Sibel ;

Vasmatzis, George ;

Yang, Ping ;

Tillmans, Lori S. ;

Johnson, Michele R. Erickson ;

Wang, Xiaoke ;

Peterson, Lisa M. ;

Halling, Kevin C. ;

Oliveira, Andre M. ;

Aubry, Marie Christine ;

Yi, Eunhee S. .

HUMAN PATHOLOGY, 2009, 40 (08) :1152-1158

[5] Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC). [J].

Camidge, D. R. ;

Bang, Y. ;

Kwak, E. L. ;

Shaw, A. T. ;

Iafrate, A. J. ;

Maki, R. G. ;

Solomon, B. J. ;

Ou, S. I. ;

Salgia, R. ;

Wilner, K. D. ;

Costa, D. B. ;

Shapiro, G. ;

LoRusso, P. ;

Stephenson, P. ;

Tang, Y. ;

Ruffner, K. ;

Clark, J. W. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[6] Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment [J].

Camidge, D. Ross ;

Kono, Scott A. ;

Flacco, Antonella ;

Tan, Aik-Choon ;

Doebele, Robert C. ;

Zhou, Qing ;

Crino, Lucio ;

Franklin, Wilbur A. ;

Varella-Garcia, Marileila .

CLINICAL CANCER RESEARCH, 2010, 16 (22) :5581-5590

[7] Oncogenic mutations of ALK kinase in neuroblastoma [J].

Chen, Yuyan ;

Takita, Junko ;

Choi, Young Lim ;

Kato, Motohiro ;

Ohira, Miki ;

Sanada, Masashi ;

Wang, Lili ;

Soda, Manabu ;

Kikuchi, Akira ;

Igarashi, Takashi ;

Nakagawara, Akira ;

Hayashi, Yasuhide ;

Mano, Hiroyuki ;

Ogawa, Seishi .

NATURE, 2008, 455 (7215) :971-U56

[8] EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors [J].

Choi, Young Lim ;

Soda, Manabu ;

Yamashita, Yoshihiro ;

Ueno, Toshihide ;

Takashima, Junpei ;

Nakajima, Takahiro ;

Yatabe, Yasushi ;

Takeuchi, Kengo ;

Hamada, Toru ;

Haruta, Hidenori ;

Ishikawa, Yuichi ;

Kimura, Hideki ;

Mitsudomi, Tetsuya ;

Tanio, Yoshiro ;

Mano, Hiroyuki .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1734-1739

[9] CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib [J].

Costa, Daniel B. ;

Kobayashi, Susumu ;

Pandya, Shuchi S. ;

Yeo, Wee-Lee ;

Shen, Zhongzhou ;

Tan, Weiwei ;

Wilner, Keith D. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :E443-E445

[10] Initial phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005 [J].

Crino, L. ;

Kim, D. ;

Riely, G. J. ;

Janne, P. A. ;

Blackhall, F. H. ;

Camidge, D. R. ;

Hirsh, V. ;

Mok, T. ;

Solomon, B. J. ;

Park, K. ;

Gadgeel, S. M. ;

Martins, R. ;

Han, J. ;

De Pas, T. M. ;

Bottomley, A. ;

Polli, A. ;

Petersen, J. ;

Tassell, V. R. ;

Shaw, A. T. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

← 1 2 3 4 5 6 7 →